Fonte: Journal of Interferon and Cytokine Research. Unidade: ICB
Assuntos: FARMACOLOGIA, IMUNOLOGIA
ABNT
CONDINO-NETO, A et al. Effect of therapy with recombinant human interferon - 'GAMA' on the release of nitric oxide by neutrophils and mononuclear cells from patients with chronic granulomatous disease. Journal of Interferon and Cytokine Research, v. 16, p. 357-64, 1996Tradução . . Acesso em: 06 out. 2024.APA
Condino-Neto, A., Muscará, M. N., Bellinati-Pires, R., Carneiro-Sampaio, M. M. S., Brandao, A. C., Grumach, A. S., & De Nucci, G. (1996). Effect of therapy with recombinant human interferon - 'GAMA' on the release of nitric oxide by neutrophils and mononuclear cells from patients with chronic granulomatous disease. Journal of Interferon and Cytokine Research, 16, 357-64.NLM
Condino-Neto A, Muscará MN, Bellinati-Pires R, Carneiro-Sampaio MMS, Brandao AC, Grumach AS, De Nucci G. Effect of therapy with recombinant human interferon - 'GAMA' on the release of nitric oxide by neutrophils and mononuclear cells from patients with chronic granulomatous disease. Journal of Interferon and Cytokine Research. 1996 ;16 357-64.[citado 2024 out. 06 ]Vancouver
Condino-Neto A, Muscará MN, Bellinati-Pires R, Carneiro-Sampaio MMS, Brandao AC, Grumach AS, De Nucci G. Effect of therapy with recombinant human interferon - 'GAMA' on the release of nitric oxide by neutrophils and mononuclear cells from patients with chronic granulomatous disease. Journal of Interferon and Cytokine Research. 1996 ;16 357-64.[citado 2024 out. 06 ]